No, you are correct Assiduous. Good news indeed. A
Post# of 36537
(Total Views: 373)
Posted On: 12/17/2020 6:02:03 PM
No, you are correct Assiduous. Good news indeed. As good as vaccine development given the likelihood of revenue from these two different opportunities. Covid vaccine is a long shot. The iikey platform, licenses in total, is much more promising, just like excellagen.
(3)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼